Historical record - last NADAC effective date: 8/19/2020
Product Information
ARIPIPRAZOLE 2 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.1782 per EA under NDC 76282004430. Its NADAC has been published 187 times since Feb 8, 2017.
FDA first approved this application on Apr 28, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282004430
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2020
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205064FDA Approved
4/28/2015
TE Code
AB
On Market Since
4/28/2015
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 2 MG TABLET has been published 187 times since Feb 8, 2017, and over the history we have for it it has declined 91.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1782 per EA |
|---|---|
| All-time high | $2.1427 (Feb 15, 2017) |
| All-time low | $0.1782 (Aug 19, 2020) |
| Median price | $0.3345 |
| Average price | $0.5252 |
| Largest weekly change | -25.3% (Apr 19, 2017) |
| Weeks tracked | 187 |
| Tracking since | Feb 8, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-91.7%
Last surveyed Sep 2, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 2 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.1782 per EA (NDC 76282004430), effective Sep 2, 2020.
How has the price of ARIPIPRAZOLE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 2 MG TABLET has declined 91.7%. It has been tracked across 187 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 2 MG TABLET?
Since Feb 8, 2017, the NADAC for ARIPIPRAZOLE 2 MG TABLET has ranged from a low of $0.1782 (Aug 19, 2020) to a high of $2.1427 (Feb 15, 2017), with a median of $0.3345 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 2 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARIPIPRAZOLE 2 MG TABLET, is $0.1146 per EA — about 36% below ARIPIPRAZOLE 2 MG TABLET.
Who manufactures ARIPIPRAZOLE 2 MG TABLET?
ARIPIPRAZOLE 2 MG TABLET (NDC 76282004430) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.